Skip to main content

DNB Fund Women's Health

DNB Fund Women's Health is an equity fund managed by DNB in the Sektor – Helse category.

About this fund

DNB Fund Women's Health is an equity fund run by DNB, compared against the Sektor – Helse peer group.

It is a recent launch, dating from 2026.

The reference index is MSCI World Health Care Index.

Anesa Mulabecirovic Sahnoun manages the fund.

Manager
DNB
Category
Sektor – Helse
Region
Global
Sector
Health Care
Style
Sector Focus
SFDR
Article 8
ISIN
LU3443186898
Inception
2026-08-18
Benchmark
MSCI World Health Care Index
AUM
9 m EUR
Returns
YTD 4.3%

Portfolio managers

Actively managedEquityGlobalHealth care
Since launch 18 Aug 2026 · NOK
+4,3 %
NOK class N
Last NAV 104,10 NOK · 12 Nov 2026
Returns by period · NOK · net
ann. 3Y+
+4,3 %
YTD
Fund size
8,6 mill. EUR
Total fund AUM
Management fee
0,85 %
Annual · class N · 0,75 %–1,50 % across 3 share classes
Ongoing charge
0,91 %
Annual · class N
Performance fee
None
Stated by the manager
Annual cost on platforms
1,20 %–1,21 %
Class N · 3 platforms · net of platform rebate, incl. platform fee, excl. transaction costs
SFDR
Article 8
Sustainability
Launched
Aug 2026
ISIN LU3443186625
BenchmarkMSCI World Health Care
Risk
Max Drawdown−7,8 %
About the fund
The fund

DNB Fund Women's Health is a global, actively managed equity fund launched in August 2026. The management company is DNB Asset Management in Oslo, the fund arm of DNB, Norway's largest bank. The company is indirectly wholly owned by DNB Bank ASA.

Investment philosophy

The fund invests in companies that develop products and services for women's health needs throughout the life course, across health care, technology and consumer sectors. The managers focus on three areas: treatment (pharmaceuticals, reproductive health and chronic disease), prevention (diagnostics, digital health solutions and health technology) and quality of life (pelvic health, nutrition and consumer health products). The fund normally invests in 35–50 companies.

The managers

Anesa Mulabecirovic Sahnoun is the lead manager and has managed the fund since its launch in August 2026. She is based in Oslo, holds a doctorate in medicine from the University of Bergen and an MBA from NHH, and has worked as a physician at Haukeland University Hospital and as an investment analyst at Hadean Ventures. She was an analyst at DNB Asset Management from June 2021 and became a manager of DNB Health Care and DNB Bioteknologi in May 2026. The fund is part of DNB Asset Management's health care team, which also manages DNB Health Care, where Rune Sand-Holm is lead manager, and DNB Bioteknologi, where Benedicte Kilander Bakke is lead manager.

The portfolio

The mandate's range of 35–50 companies lies below the median of comparable health care funds. Because the mandate also covers technology and consumer companies, the universe is broader than in a pure health care fund. The fund is new, and a lasting portfolio pattern is not yet established.

FundTelligence description · 24/10/2026
Launched 18 Aug 2026 — not ranked for this period

Portfolio managers

AN
Portfolio Manager
On the fund since Aug 18, 2026

Fund data is taken from the managers’ own reports, otherwise computed from NAV history and, as a last resort, taken from distributor listings. Not official figures; verify with the fund provider before investing.

About our data